Update of naltrexone treatment

Area of Science:

• Pharmacology
• Addiction Medicine
• Neuroscience

Background:

• Naltrexone is an opioid antagonist used in addiction treatment.
• Understanding its efficacy in a multi-modality program is crucial for improving patient outcomes.
• Identifying factors influencing long-term success is a key research area.

Purpose of the Study:

• To evaluate the effectiveness of naltrexone in a multi-modality treatment program for narcotic addiction.
• To assess the appeal and side effect profile of naltrexone in this population.
• To explore the long-term abstinence rates and potential turning points in recovery.

Main Methods:

• A self-selected population of narcotic addicts participated in a multi-modality treatment program including naltrexone.
• Patient adherence, side effects, and long-term opiate abstinence were monitored.
• Behavioral studies investigated conditioned psychophysiological responses associated with drug use.

Main Results:

• Naltrexone appealed to 5-10% of addicts consciously seeking drug-free status.
• It significantly attenuated narcotic reinforcement with minimal side effects.
• Approximately 10% of patients remaining on naltrexone for over a week were opiate-free at 6 months post-treatment.
• Extinguishing conditioned responses did not immediately improve clinical outcomes.

Conclusions:

• Naltrexone can be an effective tool for a subset of motivated narcotic addicts, potentially serving as a turning point in recovery.
• While behavioral interventions show promise, their clinical significance in conjunction with naltrexone requires further investigation.
• The study highlights the importance of patient motivation in naltrexone treatment success for opioid addiction.